BalanceD-HF: A Phase III, Randomised, Double-blind Study to Evaluate the Effect of Balcinrenone/Dapagliflozin, Compared with Dapagliflozin, on the Risk of Heart Failure Events and Cardiovascular Death in Patients with Heart Failure and Impaired Kidney Fun
2025-01-05
عنوان الدراسة
BalanceD-HF: A Phase III, Randomised, Double-blind Study to Evaluate the Effect of Balcinrenone/Dapagliflozin, Compared with Dapagliflozin, on the Risk of Heart Failure Events and Cardiovascular Death in Patients with Heart Failure and Impaired Kidney Function
داعم الدراسة
AstraZeneca
دواء الدراسة
balcinrenone/dapagliflozin
رقم بروتوكول الدراسة
D6402C00012
حالة الدراسة
Ongoing
موقع الدراسة
King Faisal Specialist Hospital and Research Center (Riyadh), King Abdulaziz Medical NG (City Riyadh),King Abdulaziz Medical City NG (Jeddah),King Fahad Medical City (Riyadh) ,King Khalid University Hospital (Riyadh)
مرحلة الدراسة
3
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。